Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pharmadrug Inc
(OP:
LMLLF
)
0.0180
-0.0019 (-9.55%)
Streaming Delayed Price
Updated: 11:22 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pharmadrug Inc
< Previous
1
2
3
4
5
6
Next >
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT
August 26, 2021
On Wednesday, PharmaDrug Inc. (CSE:PHRX) (OTC:
Via
Benzinga
Bearish Sentiment Toward Market: Cannabis Movers For July 19, 2021
July 19, 2021
GAINERS: Livewell Canada Inc (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021
July 09, 2021
GAINERS: Livewell Canada Inc (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray, KushCo And Aurora Among Top Cannabis Stock Movers On June 28, 2021
June 28, 2021
GAINERS: Mexco Energy (AMEX:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: MindMed's Nasdaq Debut, PharmaDrug Gets Orphan Drug Designation For DMT, Numinus Launches Clinical Trial Of Naturally Derived Psilocybin
May 04, 2021
PharmaDrug Inc. (CSE:BUZZ) (OTC:
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.